Ingemar Kihlström
Extensive experience in finance and drug development at multiple firms including Astra Zeneca and Pharmacia. PhD in physiology/toxicology from Uppsala University. Experience from serving at the board of >30 companies often as chairman. Co-founder of life science companies and managed several licensing deals and IPOs in the industry.
See longer interview